Mimedx Group Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$4.10

-0.06 (-1.44%)

As of Aug 8, 1:48 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 91%

Hold 1 9%

Sell 0 0%

Price Target

Analyst Price Target +489.0% upside

Low Target $19.42

Average Target $24.15

High Target $35.38

Current Price $4.10

Current
$4.10

Target
$24.15

$19.42 $24.15 avg $35.38

Scenario Analysis

Bear Case

$19.42

373.7%

Low target

Base Case

$24.15

+489.0%

Avg target

Bull Case

$35.38

+762.9%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$7.97

-48.6% from high

52-Week Low

$3.03

+35.3% from low

Target vs 52W High

$24.15

+203.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	79%	$257.58	+4.7%
AMGN Amgen Inc	Hold	43	49%	$190.87	-53.6%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+172.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.6%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-90.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-55.6%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-44.4%
BIIB Biogen Inc	Buy	44	64%	$91.45	-56.0%